Oct. 29 - Rate of kidney damage in Crestor patients is 75 times higher than in patients taking other cholesterol drugs

The rate of reports of kidney failure or damage among patients taking the cholesterol drug Crestor is 75 times higher than in all patients taking all other statins, according to a Public Citizen analysis of government data.

To read the press release, click here.

To read Public Citizen's letter to the FDA, click here.

To get more information about Crestor and other prescription drugs, click here.

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.